Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.47 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.47 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.47 |
| ▸ | TTR | P02766 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | CALM1 | P0DP23 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29410297 | 1.00 | CYP3A4 (0.50) | CYP3A4PTGS2CYP1A1CYP1B1TTR | |
| SCHEMBL233829 | 0.82 | ALDH1A1 (0.69) | CYP3A4PTGS2CYP1A1CYP1B1TTR | |
| Flamenol SCHEMBL69428 | 0.82 | CYP3A4 (0.62) | CYP3A4PTGS2CYP1A1CYP1B1TTR | |
| SCHEMBL811578 | 0.82 | ALDH1A1 (0.59) | CYP3A4CYP1A1CYP1B1ALDH1A1TP53 | |
| SCHEMBL21263 | 0.82 | ALDH1A1 (0.69) | CYP3A4PTGS2CYP1A1CYP1B1TTR | |
| SCHEMBL6122883 | 0.80 | HSP90AA1 (0.54) | CYP3A4ALDH1A1MEN1HPGDKMT2A | |
| SCHEMBL1816933 | 0.79 | ALDH1A1 (0.65) | CYP3A4PTGS2CYP1A1CYP1B1TTR | |
| Flamenol SCHEMBL3190965 | 0.79 | CYP3A4 (0.59) | CYP3A4PTGS2CYP1A1CYP1B1TTR | |
| SCHEMBL28298270 | 0.79 | ALDH1A1 (0.65) | CYP3A4PTGS2CYP1A1CYP1B1TTR | |
| SCHEMBL29210999 | 0.78 | HCAR1 (0.41) | CYP3A4ALDH1A1HPGDHSD17B10BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 294 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019028600-A1 | PROCESS FOR PRODUCTION OF CARBOXYLATED PHENOL DERIVATIVES | RHODIA OPERATIONS (FR) | 2019-02-14 | — | — | WO | claimed |
| US-10029992-B2 | Diaminotriazine compounds and their use as herbicides | BASF SE (DE) | 2018-07-24 | — | — | US | claimed |
| EP-3134391-A1 | DIAMINOTRIAZINE COMPOUNDS AND THEIR USE AS HERBICIDES | BASF SE (DE) | 2017-03-01 | — | — | EP | claimed |
| US-20170044114-A1 | Diaminotriazine compounds and their use as herbicides | BASF SE (DE) | 2017-02-16 | — | — | US | claimed |
| WO-2015162166-A1 | DIAMINOTRIAZINE COMPOUNDS AND THEIR USE AS HERBICIDES | BASF SE (DE) | 2015-10-29 | — | — | WO | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| EP-0299890-B1 | PROCESS FOR THE CHLORINATION OF PHENOLIC COMPOUNDS | RHONE-POULENC CHIMIE (FR) | 1991-12-11 | — | — | EP | claimed |
| EP-0283411-B1 | PROCESS FOR CHLORINATING PHENOLIC COMPOUNDS | RHONE-POULENC CHIMIE (FR) | 1991-08-07 | — | — | EP | claimed |
| EP-0255452-B1 | PROCESS FOR CHLORINATING PHENOLIC COMPOUNDS | RHONE-POULENC CHIMIE (FR) | 1990-01-24 | — | — | EP | claimed |
| EP-0299890-A1 | Process for the chlorination of phenolic compounds | RHONE-POULENC CHIMIE (FR) | 1989-01-18 | — | — | EP | claimed |
| EP-0283411-A1 | Process for chlorinating phenolic compounds | RHONE-POULENC CHIMIE (FR) | 1988-09-21 | — | — | EP | claimed |
| EP-0255452-A1 | Process for chlorinating phenolic compounds | RHONE-POULENC CHIMIE (FR) | 1988-02-03 | — | — | EP | claimed |
| EP-0211775-A1 | Process for nitrating phenolic compounds | RHONE-POULENC CHIMIE (FR) | 1987-02-25 | — | — | EP | claimed |
| US-12433160-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2025-09-30 | — | — | US | disclosed |
| US-12421193-B2 | GPR52 modulators and methods of use | NEUROCRINE BIOSCIENCES, INC. (US) | 2025-09-23 | — | — | US | disclosed |
| EP-4596551-A1 | COMPOUNDS WITH ANTI-KRAS MUTANT TUMOR ACTIVITY | Trasveda Ltd. (KY) | 2025-08-06 | — | — | EP | disclosed |
| US-3954782-A | 2,6-Hydrazino-3-pyridine carboxyamides | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-05-04 | — | — | US | disclosed |
| US-3947463-A | Certain 2-amino-nicotinonitrile derivatives | CASSELLA FARBWERKE MAINKUR AG (DT) | 1976-03-30 | — | — | US | disclosed |
| US-3946024-A | INTERMEDIATES FOR AZO DYES | CASSELLA FARBWERKE MAINKUR AG (DT) | 1976-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12433160-B2 | Materials for organic electroluminescent devices | OR10J3, L1CAM, EPCAM | CYP3A4 1039/4885PTGS2 2459/4885CYP1A1 2019/4885 |
| US-10029992-B2 | Diaminotriazine compounds and their use as herbicides | NR4A3, CBR3, RCOR3 | CYP3A4 2369/4885PTGS2 2846/4885CYP1A1 364/4885 |
| US-12421193-B2 | GPR52 modulators and methods of use | GPR52, GPR68, GPR35 | CYP3A4 2659/4885PTGS2 333/4885CYP1A1 2102/4885 |
| US-20170044114-A1 | Diaminotriazine compounds and their use as herbicides | NR4A3, CBR3, RCOR3 | CYP3A4 2402/4885PTGS2 2869/4885CYP1A1 373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.